Nicholas Robert Lemoine,[2] CBE, FRCPath, FMedSci (born December 1957[3]) is a British academic, professor at Queen Mary University of London, director of the Barts Cancer Institute and centre lead, Centre for Molecular Oncology.[4][5]
Lemoine's main interests are "the genomics and molecular pathology of pancreatic cancer and the development of oncolytic virotherapy".[5]
He was educated at Abingdon School[6] from 1971 until 1976 before studying medicine at St Bartholomew's Hospital Medical College from 1977 until 1983.[7]
Lemoine was appointed Commander of the Order of the British Empire (CBE) in the 2022 New Year Honours for services to clinical research, particularly during COVID-19.[8]
YouTube Encyclopedic
-
1/3Views:2 4911 2661 255
-
Dr David Kirn on developments in oncolytic virotherapy for cancer
-
Gene Therapy for Heart Disease.mov
-
Professor Xiao Xiao on Gene Therapy for Muscular Dystrophy
Transcription
See also
References
- ^ "Births". Free BMD.
- ^ "Foreign Academicians Bring Global Perspective to Chinese Scientists". English Chinese Academy of Sciences.
- ^ "Nicholas LEMOINE - Personal Appointments (free information from Companies House)". Retrieved 10 December 2016.
- ^ "Meet the researchers - Professor Nick Lemoine · What we do · Pancreatic Cancer Research Fund". Retrieved 10 December 2016.
- ^ a b Lemoine, Nick. "Professor Nick Lemoine - Barts Cancer Institute". Retrieved 10 December 2016.
- ^ "Officers of the School" (PDF). The Abingdonian.
- ^ "Nick Lemoine". oncology-central.com.
- ^ "No. 63571". The London Gazette (Supplement). 1 January 2022. p. N9.
This page was last edited on 3 June 2023, at 11:52